Estrabet est une préparation pharmaceutique contenant Valérate d'estradiol, an esterified form of 17β-estradiol, the primary endogenous estrogen hormone in humans. Estradiol valerate is widely used in hormone-related pharmaceutical formulations due to its reliable absorption profile and conversion into active estradiol after administration.
Estrabet is recognized in endocrine and pharmaceutical contexts as an oral estrogen formulation used in hormone-related therapies and research involving estrogenic signaling pathways.
Principe actif
Valérate d'estradiol
- Classe : Estrogen hormone / estradiol ester
- Chemical type: Synthetic ester of 17β-estradiol
- Mécanisme : Hydrolyzed in vivo into active estradiol, which binds to estrogen receptors (ERα and ERβ).
Chemical & Pharmacological Properties
- Chemical name: Estradiol valerate
- Molecular formula: C23H32O3
- Molecular weight: 356.5 g/mol
- Administration form: Oral tablets
- Appearance: Film-coated pharmaceutical tablets
Estradiol valerate acts as a prodrug, gradually converting into estradiol after absorption, allowing sustained estrogenic activity.
Mécanisme d'action
After administration, estradiol valerate undergoes enzymatic cleavage to release active estradiol.
Estradiol then:
- Binds to intracellular estrogen receptors
- Regulates transcription of estrogen-responsive genes
- Influences reproductive, skeletal, cardiovascular, and neurological systems
Physiological Effects of Estrogenic Activity
- Modulation of endocrine signaling
- Effects on lipid metabolism
- Influence on bone density and calcium regulation
- Regulation of secondary sexual characteristics
- Vascular and skin-related effects
Research & Pharmaceutical Applications
Estrabet and estradiol valerate formulations are studied in:
- Endocrinology and hormone signaling research
- Estrogen receptor pharmacology
- Hormonal regulation studies
- Pharmaceutical stability and bioavailability analysis
- Menopause and reproductive hormone investigations
Sécurité et manipulation
Estrogen-containing pharmaceutical products require careful handling and appropriate medical supervision.
Possible Side Effects
- Nausées
- Fluid retention
- Sensibilité mammaire
- Maux de tête
- Changements de la tension artérielle
- Mood alterations
Potential Risks
- Thromboembolic risk in predisposed individuals
- Hormone-sensitive condition considerations
- Drug interactions involving liver metabolism pathways
Conditions de conservation
- Conserver entre 15 et 25 °C
- Protect from direct light and moisture
- Keep in original packaging
Statut réglementaire
Estradiol valerate is a regulated pharmaceutical hormone ingredient in many countries and may require prescription authorization depending on jurisdiction.
Résumé
Estrabet contains Valérate d'estradiol, a well-established oral estrogen formulation used in endocrine and pharmaceutical contexts. Through conversion to active estradiol, it supports research and therapeutic applications involving estrogen receptor signaling and hormonal regulation.
Avis
Il n’y a pas encore d’avis.